Hepatocellular carcinoma

By Alejandro Forner1 , 2, J. Llovet, Jordi Bruix1 , 2. The Lancet, 2012

830 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/67b6a8ec963390206d9b1d5ca6f8a66d1cbb4bf1

Citations in the corpus

• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. (2018, neutral): “If a patient is not a candidate for liver transplant, the availability of the pathology characteristics will not change the treatment strategy and thus, RFA might become the first-line option (see chapter ‘resection’), leaving surgery for those patients with nodules not suitable for RFA, or who fail”